![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
HJ Duff, J Offord, J West and WA Catterall
Department of Pharmacology, University of Washington, Seattle 98195.
Previous studies have shown that chronic in vivo treatment with the antiarrhythmic drug mexiletine produces an increase in sodium channel number. We examined whether chronic mexiletine treatment would similarly regulate the level of mRNA encoding the cardiac sodium channel. RNA isolated from cardiac tissue was probed with a 2.5- kilobase cRNA transcribed with T7 RNA polymerase from the clone Na 8.4, which encodes nucleotides 3361-5868 of the alpha subunit of the RIIA sodium channel subtype. Chronic mexiletine treatment produced a 3-fold increase in the level of mRNA encoding sodium channel alpha subunits. Previous studies of cultured skeletal muscle cells had suggested that chronic sodium channel blockade may mediate an increase in sodium channel mRNA by changes in cytosolic Ca2+ concentration. To address this issue, we assessed whether verapamil would also produce up- regulation of the level of mRNA encoding the sodium channel and whether the calcium ionophore A23187 would produce the opposite effect on mRNA level. Verapamil treatment increased sodium channel mRNA level up to 3- fold, whereas in vitro A23187 treatment decreased the mRNA level 5- fold. The combination of verapamil and mexiletine produced no further increase in the mRNA level, compared with that seen with the single agents, suggesting a convergent second messenger pathway for the actions of these two drugs. These data show that the level of mRNA encoding sodium channels is substantially increased during antiarrhythmic drug treatment and suggest that change in cytosolic Ca2+ concentration is the second messenger involved in the regulation of levels of mRNA encoding the alpha subunit of the cardiac sodium channel.
This article has been cited by other articles:
|
|
 |
|
  A.-L. Leoni, C. Marionneau, S. Demolombe, S. L. Bouter, M. E. Mangoni, D. Escande, and F. Charpentier Chronic heart rate reduction remodels ion channel transcripts in the mouse sinoatrial node but not in the ventricle Physiol Genomics, December 14, 2005; 24(1): 4 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Xu, Z. Zhang, V. Timofeyev, D. Sharma, D. Xu, D. Tuteja, P. H. Dong, G. U. Ahmmed, Y. Ji, G. E Shull, et al. The effects of intracellular Ca2+ on cardiac K+ channel expression and activity: novel insights from genetically altered mice J. Physiol., February 1, 2005; 562(3): 745 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Rosati and D. McKinnon Regulation of Ion Channel Expression Circ. Res., April 16, 2004; 94(7): 874 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R Valdivia, M. J Ackerman, D. J Tester, T. Wada, J. McCormack, B. Ye, and J. C Makielski A novel SCN5A arrhythmia mutation, M1766L, with expression defect rescued by mexiletine Cardiovasc Res, August 1, 2002; 55(2): 279 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. L.J.L. Thijssen, J. Ausma, and M. Borgers Structural remodelling during chronic atrial fibrillation: act of programmed cell survival Cardiovasc Res, October 1, 2001; 52(1): 14 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Leaf The electrophysiological basis for the antiarrhythmic actions of polyunsaturated fatty acids Eur. Heart J. Suppl., June 1, 2001; 3(suppl_D): D98 - D105. [Abstract] [PDF]
|
|
|
|
|
|
D. M. Roden and S. Kupershmidt From genes to channels: normal mechanisms Cardiovasc Res, May 1, 1999; 42(2): 318 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Yue, P. Melnyk, R. Gaspo, Z. Wang, and S. Nattel Molecular Mechanisms Underlying Ionic Remodeling in a Dog Model of Atrial Fibrillation Circ. Res., April 16, 1999; 84(7): 776 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Gaspo, R. F. Bosch, E. Bou-Abboud, and S. Nattel Tachycardia-Induced Changes in Na+ Current in a Chronic Dog Model of Atrial Fibrillation Circ. Res., December 19, 1997; 81(6): 1045 - 1052. [Abstract] [Full Text]
|
|
|
|
|
|
J. Pu and P. A. Boyden Alterations of Na+ Currents in Myocytes From Epicardial Border Zone of the Infarcted Heart : A Possible Ionic Mechanism for Reduced Excitability and Postrepolarization Refractoriness Circ. Res., July 19, 1997; 81(1): 110 - 119. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. X. Kang, Y. Li, and A. Leaf Regulation of sodium channel gene expression by class I antiarrhythmic drugs and n - 3 polyunsaturated fatty acids in cultured neonatal rat cardiac myocytes PNAS, March 18, 1997; 94(6): 2724 - 2728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. X. Kang and A. Leaf Antiarrhythmic Effects of Polyunsaturated Fatty Acids: Recent Studies Circulation, October 1, 1996; 94(7): 1774 - 1780. [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
